The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care. The new cobas c 703 ...
With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs This will allow a greater number of ...
Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its newest analytical units – the cobas® c 703 and cobas® ISE neo. As part of the scalable and modular cobas® pro ...
With a footprint of just two square meters, this new analyser provides small to medium sized labs with access to more than 230 diagnostic tests2 across a wide-range of disease areas including ...
Roche Diagnostics India announced the launch of latest diagnostic technology - cobas pro integrated solutions - which brings to India’s IVD labs an opportunity to establish several ‘first-of-its-kind’ ...
INDIANAPOLIS, July 22, 2026 /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, Roche will showcase integrated ...
* ROCHE DIAGNOSTICS ANNOUNCED TODAY THAT US FOOD AND DRUG ADMINISTRATION (FDA) HAS CLEARED ITS COBAS PROⓇ INTEGRATED SOLUTIONS, A NEW GENERATION OF SERUM WORK AREA (CLINICAL CHEMISTRY AND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results